Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.2.0.727
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Percentage of Revenue 63.00% 100.00%
Sarif Biomedical LLC [Member]    
License Amount $ 325,000  
Percentage of Revenue 24.00%  
Selene Communication Technologies [Member]    
License Amount $ 150,000 $ 75,000
Percentage of Revenue 11.00% 2.00%
E2E [Member]    
License Amount $ 140  
Percentage of Revenue 10.00%  
MedTech GmbH [Member]    
License Amount $ 131,420  
Percentage of Revenue 9.00%  
E2E 2 [Member]    
License Amount $ 120,000  
Percentage of Revenue 9.00%  
CRFD [Member]    
License Amount $ 2,800,000  
Percentage of Revenue 73.00%  
IP Liquidity Ventures [Member]    
License Amount $ 937,500  
Percentage of Revenue 2.40%  
Vantage [Member]    
License Amount $ 11,000  
Percentage of Revenue 0.00%  
CyberFone [Member]    
License Amount $ 1,000  
Percentage of Revenue 0.00%